Trial
NCT05720624
Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Malignant Central Nervous System Neoplasm
Intervention
Anhydrous Enol-oxaloacetate
Why stopped
Funding issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-22